- Life Sciences - Aug 24 Genome mapped in battle to beat superbugs
- Medicine - Aug 24 Stand up at work and be counted
- Medicine - Aug 23 Berkeley’s soda tax linked to less thirst for sugary drinks
- Medicine - Aug 23 $1M NIH grant helps researchers refine quick cancer test
- Life Sciences - Aug 23 $1.3M NIH grant funds brain development, cancer research
- Life Sciences - Aug 23 CaSB@Yale launches with $9.5M federal grant to battle deadliest cancers
- Medicine - Aug 23 New Baker Institute director inspired by Cornell
- Medicine - Aug 23 Research note: The immune system- body weight connection
- Life Sciences - Aug 23 MRI scan may help diagnose chronic traumatic encephalopathy, UCLA researchers report
- Medicine - Aug 23 Reframing body weight as baby weight may help women handle pregnancy
- Mechanical Engineering - Aug 23 The art of science
- Medicine - Aug 22 Stanford chemists develop a new method of cancer immunotherapy
- Physics - Aug 22 A new eye on the middle ear
- Life Sciences - Aug 22 Solving the mystery of meningiomas reveals a surprise twist
- Medicine - Aug 22 Australia’s longest- running women’s health study to add children’s data
- Medicine - Aug 22 Machine learning to unlock Parkinson’s disease mystery »
Director appointed for inflammation research centre
The University of Manchester, GlaxoSmithKline (GSK) and AstraZeneca have appointed Professor Tracy Hussell as Director of the new Manchester Collaborative Centre for Inflammation Research (MCCIR).
The MCCIR is a unique collaboration announced in May last year to establish a world-leading translational centre for inflammatory diseases with an initial investment of £5 million from each partner over a three year period.
Professor Hussell is currently Professor of Inflammatory Disease at the National Heart and Lung Institute at Imperial College London where she has developed a vibrant research group studying immunity, pathology and vaccination in influenza virus infection with a special interest in the secondary bacterial complications that can ensue.
Professor Hussell’s research has identified novel strategies to alleviate inflammatory disorders. Her group has pioneered the concept of, and is still working on, how one inflammatory condition modulates the severity of the next. Importantly, she has identified that the activation of an immune response changes depending on which organ of the body it is in. Understanding tissue specific regulation of immunity reveals novel methods to treat inflammatory disorders.
Professor Hussell said: “This new centre provides a unique opportunity, working not only with the academic and medical resources of Manchester University, but also with pharmaceutical industry. I am very proud to have been chosen to lead the centre and, naturally, I am hugely excited by the prospect of guiding it into a world leading institution for translational research and innovation”.
The MCCIR collaboration between two UK-based pharmaceutical companies, GSK and AstraZeneca, and The University of Manchester, a premier research-led institution, will bring together scientists from both the pharmaceutical industry and academia to work collaboratively on inflammation research and translational medicine.
Speaking of the new appointment, Professor Ian Jacobs, University Vice-President and Dean of the Faculty of Medical and Human Sciences and Chair of the MCCIR Board said: “I am delighted that we have appointed a scientist of Tracy’s quality and reputation to direct MCCIR. This is a unique venture that will link with areas of strength in cancer, inflammatory disease, cardiovascular disease and human development across The University of Manchester and Manchester Academic Health Science Centre. Tracy’s recruitment is a key step in a series of initiatives and appointments which will ensure that MCCIR has an international impact.”
Professor Martin Humphries, University Vice-President and Dean of the Faculty of Life Sciences, added: “The MCCIR is a unique collaboration between AstraZeneca, GSK and the University that aims to deliver ground-breaking basic and translational research in inflammation and inflammatory disease. The initiative therefore requires someone with Tracy’s track record, vision and drive to succeed, and I am delighted that she has agreed to join us to lead the Centre.”
MCCIR Board Member Roberto Solari, from GSK, said: “This partnership between the University, AstraZeneca and GSK is a truly groundbreaking initiative and we are all tremendously excited about Tracy’s appointment as director. We are confident that under her leadership the MCCIR will become an international centre of excellence that will deliver real innovation and ultimately bring benefit to patients.”
Menelas Pangalos, Executive Vice President of Innovative Medicines at AstraZeneca, added: "AstraZeneca recognises the importance of this collaboration with the University and GSK as we need to work and think differently if we are to solve challenging scientific and medical problems underlying inflammatory disease. Tracy’s appointment and her leadership of the MCCIR will enhance our efforts to speed the search for innovative new medicines that could help millions of people."
Professor Hussell is a principal investigator in the Medical Research Council/Asthma UK Centre in Allergic Mechanisms of Asthma, and in the Centre for Respiratory Infection. She is also a member of the research committee for Asthma UK and has contributed significantly to British Immunology as Secretary for the Clinical Immunology and Allergy Section of the Royal Society of Medicine and as the Education Secretary and a Trustee of the British Society for Immunology.
Last job offers
- Agronomy/Food Science - 19.8
Senior Manager of Animal Tissues (100%)
- Life Sciences - 18.8
Wissenschaftliche Mitarbeiterin / Wissenschaftlichen Mitarbeiter Luft- und Wasserreinheit in Gebäuden...
- Medicine/Pharmacology - 17.8
Scientific Expert in Quality Control
- Life Sciences - 17.8
Project Manager, Production Upscale (100%)
- Medicine/Pharmacology - 11.8
Professeur-e et médecin-chef-fe du service de médecine interne générale
- Life Sciences - 9.8
Faculty Position in Bioengineering
- Medicine/Pharmacology - 23.8
Assistant professor in qualitative active living research
- Medicine/Pharmacology - 21.8
Fellow/ Associate Professor
- Life Sciences - 16.8
Professur für Biophysik
- Veterinary Science - 19.8
- Medicine/Pharmacology - 18.8
Professur (W2) auf Zeit (5 Jahre)
- Medicine/Pharmacology - 23.8
Professor of Clinical Trials
- Chemistry - 22.8
Associate Professor / Reader in Medicinal Chemistry
- Chemistry - 20.8
- Administration/Government - 19.8
Assistant or Associate Professor